Coping Strategies for Dealing With the Release of Medicare Data
STUART MICHAELSON, CONTRIBUTING EDITOR
Patience and positivity stressed in dealing with reimbursement fallout
Switching Anti-VEGF Agents In Eyes With Treatment-resistant Neovascular AMD
ROBERTO GALLEGO-PINAZO, MD, PhD • ROSA DOLZ-MARCO, MD, PhD • SARAH MREJEN, MD • K. BAILEY FREUND, MD
Determining when a change is warranted
Add-on IOLs for Vitrectomized Silicone Oil–filled Eyes
GÁBOR B. SCHARIOTH, MD, PhD
Using a special intraocular lens, surgeons can mitigate postvitrectomy hyperopia.
A Checklist for EHR For Retina Practices
RISHI P. SINGH, MD
Electronic health records will soon be mandatory, but you can ease the transition.
Intravitreal Injections Without Access to Retinal Specialists
KAREN BLUM, CONTRIBUTING EDITOR
Some patients are turning to general ophthalmologists to perform intravitreal injections.
The Economics of Anti-VEGF Treatment
ADAM WEBER, MD • ANDREW P. SCHACHAT, MD
With ophthalmic drugs bearing high costs, economic burden can play a key role in treatment.
Observational Management Of Suprachoroidal Hemorrhage
ALEXANDER WEISS, BA • CHRISTOPHER R. HENRY, MD • HARRY W. FLYNN, JR., MD
Three cases of massive hemorrhage that resolved with observation
Imaging the Evolution of Dry AMD: Part II
MARCO A. ZARBIN, MD, PhD • PHILIP J. ROSENFELD, MD, PhD
In the second of two articles, the authors examine how new modalities are changing how clinicians see this disease.
Peter K. Kaiser, MD
BY JERRY HELZNER, SENIOR EDITOR
Innovation in Retina
EDITED BY EMMETT T. CUNNINGHAM, JR, MD, PhD, MPH, AND PRAVIN U. DUGEL, MD
Hampar and Vicken Karageozian
CONTROVERSIES IN CARE
EDITED BY MICHAEL COLUCCIELLO, MD
BY SUZANNE CORCORAN, COE
Interpretation and Report: What’s It Mean?